Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
AZN
AZN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AZN News
AstraZeneca Receives FDA Priority Review for New Drug
4d ago
Yahoo Finance
Future Outlook for Obesity Drugs Market
6d ago
CNBC
Future Outlook for Obesity Medications
6d ago
Newsfilter
AstraZeneca's Truqap Approved by FDA for Prostate Cancer Treatment
6d ago
NASDAQ.COM
AstraZeneca's TRUQAP Approved for Prostate Cancer Treatment
Jun 12 2026
Newsfilter
AstraZeneca's Truqap Receives FDA Label Expansion Approval
Jun 12 2026
seekingalpha
Performance Analysis of iShares International ETFs
Jun 10 2026
NASDAQ.COM
Analysis of Growth Potential in International ETFs
Jun 10 2026
Fool
AstraZeneca Advances Elecoglipron to Phase 3 Trials
Jun 08 2026
seekingalpha
Foundayo Approved by FDA; Lilly to Seek Type 2 Diabetes Approval
Jun 08 2026
stocktwits
Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors
Jun 08 2026
Yahoo Finance
AstraZeneca CEO Highlights AI's Role in Drug Development
Jun 06 2026
Yahoo Finance
AstraZeneca CEO Discusses AI's Role in Drug Development
Jun 05 2026
CNBC
AstraZeneca CEO Discusses AI's Role in Drug Development
Jun 05 2026
Newsfilter
NYSE Daily Pre-Market Update Highlights Key Listings
Jun 05 2026
PRnewswire
AstraZeneca's Kidney Cancer Treatment Shows Progress
Jun 01 2026
seekingalpha
Show More News
